References
- Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277–300.
- Zelefsky MJ, Moughan J, Owen J, Zietman AL, Roach M, Hanks GE. Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancer. Int J Radiat Oncol Biol Phys 2004;59:1053–61.
- European Association of Urology. Guidelines on prostate cancer 2013. Available from http://www.uroweb.org/gls/pdf/09_Prostate_Cancer_LR.pdf; [Last accessed December 2013].
- Lund L, Borre M, Jacobsen J, Sorensen HT, Norgaard M. Impact of comorbidity on survival of Danish prostate cancer patients, 1995–2006: a population-based cohort study. Urology 2008;72:1258–62.
- Berglund A, Garmo H, Tishelman C, Holmberg L, Stattin P, Lambe M. Comorbidity, treatment and mortality: a population based cohort study of prostate cancer in PCBaSe Sweden. J Urol 2011;185:833–9.
- Daskivich TJ, Chamie K, Kwan L, Labo J, Dash A, Greenfield S, et al. Comorbidity and competing risks for mortality in men with prostate cancer. Cancer 2011;117:4642–50.
- Daskivich TJ, Chamie K, Kwan L, Labo J, Palvolgy R, Dash A, et al. Overtreatment of men with low-risk prostate cancer and significant comorbidity. Cancer 2011;117:2058–66.
- Schymura MJ, Kahn AR, German RR, Hsieh MC, Cress RD, Finch JL, et al. Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1). BMC Cancer 2010;10:152.
- Marr PL, Elkin EP, Arredondo SA, Broering JM, DuChane J, Carroll PR. Comorbidity and primary treatment for localized prostate cancer: data from CaPSURE. J Urol 2006;175:1326–31.
- Houterman S, Janssen-Heijnen ML, Hendrikx AJ, van den Berg HA, Coebergh JW. Impact of comorbidity on treatment and prognosis of prostate cancer patients: a population-based study. Crit Rev Oncol Hematol 2006;58:60–7.
- Chamie K, Daskivich TJ, Kwan L, Labo J, Dash A, Greenfield S, et al. Comorbidities, treatment and ensuing survival in men with prostate cancer. J Gen Intern Med 2012;27:492–9.
- Post PN, Kil PJ, Hendrikx AJ, Janssen-Heijnen ML, Crommelin MA, Coebergh JW. Comorbidity in patients with prostate cancer and its relevance to treatment choice. BJU Int 1999;84:652–6.
- Post PN, Hansen BE, Kil PJ, Janssen-Heijnen ML, Coebergh JW. The independent prognostic value of comorbidity among men aged < 75 years with localized prostate cancer: a population-based study. BJU Int 2001;87:821–6.
- Houterman S, Janssen-Heijnen ML, Verheij CD, Kil PJ, van den Berg HA, Coebergh JW. Greater influence of age than co-morbidity on primary treatment and complications of prostate cancer patients: an in-depth population-based study. Prostate Cancer Prostatic Dis 2006;9:179–84.
- Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry – history, content, quality and use. Dan Med Bull 1997;44:535–9.
- Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011;39:30–3.
- Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83.
- Pedersen CB. The Danish Civil Registration System. Scand J Public Health 2011;39:22–5.
- Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sorensen HT. The predictive value of ICD‐10 diagnostic coding used to assess Charlson comorbidity index conditions in the population‐based Danish National Registry of Patients. BMC Med Res Methodol 2011;11:83.
- Hines RB, Chatla C, Bumpers HL, Waterbor JW, McGwin GJr, Funkhouser E, et al. Predictive capacity of three comorbidity indices in estimating mortality after surgery for colon cancer. J Clin Oncol 2009;27:4339–45.
- Danish Urological Cancer Group. 2012; [In Danish]. Available from. http://ducg.dk/fileadmin/www.ducg.dk/6_Stadieinddeling.pdf; [Last accessed December 2013].
- Abdollah F, Briganti A, Suardi N, Gallina A, Capitanio U, Salonia A, et al. Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy? Prostate Cancer Prostatic Dis 2011;14:74–8.
- Kang J, Chen MH, Zhang Y, Moran BJ, Dosoretz DE, Katin MJ, et al. Type of diabetes mellitus and the odds of Gleason score 8 to 10 prostate cancer. Int J Radiat Oncol Biol Phys 2012;82:e463–7.